1227923-29-6,
MK7622,
MK-7622,
3-[(1S,2S)-2-Hydroxycyclohexyl]-6-[(6-methyl-3-pyridinyl)methyl]benzo[h]quinazolin-4(3H)-one,
MK 7622,
3-((1S,2S)-2-Hydroxycyclohexyl)-6-((6-methylpyridin-3-yl)methyl)benzo[h]quinazolin-4(3H)-one,
3-[(1S,2S)-2-hydroxycyclohexyl]-6-[(6-methylpyridin-3-yl)methyl]benzo[h]quinazolin-4(3H)-one,
SCHEMBL2399084,
CHEMBL4078588,
EX-A804,
JUVQLZBJFOGEEO-GOTSBHOMSA-N,
BCP27739,
MFCD22419022,
ZINC95930184,
AKOS028113668,
CS-5442,
DB12897,
AS-35236,
Benzo(H)quinazolin-4(3H)-one, 3-((1S,2S)-2-hydroxycyclohexyl)-6-((6-methyl-3-pyridinyl)methyl)-,
HY-15618,
J-690076,
UNII-57R7D1Q49R component JUVQLZBJFOGEEO-GOTSBHOMSA-N,
N-{3-[5-(2-Hydroxy-2-propanyl)-1,2,4-oxadiazol-3-yl]benzyl}-2-(2-pyridinyl)-5-pyrimidinecarboxamide,
M1 receptor modulator,
M1 receptor,
D02WFN,
UNII-57R7D1Q49R,
57R7D1Q49R,